Orthobiologics Market Analysis, Size, Trends | Japan | 2020-2026 | MedSuite
- Year: 2020
- Scope: 2016-2026
- Region: Japan
- Pages: 187
- Published Date: 02/14/2020
- Type: MedSuite
In 2020, the Japanese orthobiologics market size was valued at $426.9 million, with over 221,000 bone grafting procedures performed every year. The market size is expected to fluctuate over the forecast period with a -0.4% compound annual growth rate (CAGR).
Throughout this medical market research, we analyzed 16 orthobiologics companies across Japan and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.
While this MedSuite report contains all of the Japanese Orthopedic Biomaterials market data and analysis, each of the market segments is also available as stand-alone MedCore reports. This allows you to get access to only the market research that you need.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Orthobiologics Procedure Volumes
- Market Forecasts Until 2026, and Historical Data to 2016
- Competitive Analysis with Market Shares for Each Segment
- Market Drivers & Limiters for Each Orthopedic Biomaterials Device market
- Recent Mergers & Acquisitions
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
Market Value and Industry Trends
A lack of product differentiation across similar injection cycle products has led to commoditization, which has stifled innovation and the further development of new products. The prices of HA viscosupplementation products in Japan have drastically decreased since their introduction and are among the lowest in the world.
Surgical procedures that require the use of orthopedic biomaterials are generally associated with diseases and indications that become more prevalent in the population with an increase in age, such as osteoarthritis of the spine and knee. In 2019, approximately 29% of the Japanese population were aged 65 and over; this proportion is projected to grow steadily over the forecast period, as further cohorts of baby boomers turn 65. Growth of this population is expected to stimulate growth across all segments of the orthopedic biomaterials market.
In August 2018, Medtronic received PMDA approval for its Grafton® DBM allograft product, which is the first DBM allograft to be approved in Japan. Grafton® was commercially launched in February 2019. The growth of this product will be primarily driven by spine procedures and other orthopedic procedures that it is indicated for.
By 2020, the leading competitor in the Japanese orthopedic biomaterials market was Seikagaku, which was attributed to its dominant position in the HA viscosupplementation market. The company’s portfolio includes the five-injection ARTZ® product line.
Chugai was the second-leading competitor in the Japanese market, which was attributed to its second-leading position in the HA viscosupplementation market. The company’s portfolio includes the Suvenyl® product line.
Click on each title to view more detailed market segmentation.
- Procedure Volumes for Orthopedic Biomaterials Devices – MedPro – The complete procedural analysis for each segment of the Japanese Orthopedic Biomaterials market.
- Orthopedic Bone Graft Substitute Market – MedCore – This market is further segmented by Indication, including Spine, Trauma, Large Joint Reconstruction, Craniomaxillofacial, and Oncology.
- Hyaluronic Acid Viscosupplementation Market – MedCore – This market is categorized by Treatment Type, including Three-Injection and Five-Injection.
Detailed Market Segmentation
DON’T SEE THE SEGMENT OR DATA YOU NEED?
Feel free to contact us or send a request by pressing one of the buttons below.
TABLE OF CONTENTS FOR JAPANESE ORTHOPEDIC BIOMATERIALS MARKET REPORT SUITETABLE OF CONTENTS ILIST OF FIGURES VIILIST OF CHARTS XIIEXECUTIVE SUMMARY 1JAPANESE ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW 1COMPETITIVE ANALYSIS 3MARKET TRENDS 5MARKET DEVELOPMENTS 6PROCEDURE NUMBERS 7MARKETS INCLUDED 8VERSION HISTORY 8RESEARCH METHODOLOGY 9Step 1: Project Initiation & Team Selection 9Step 2: Prepare Data Systems and Perform Secondary Research 12Step 3: Preparation for Interviews & Questionnaire Design 14Step 4: Performing Primary Research 15Step 5: Research Analysis: Establishing Baseline Estimates 17Step 6: Market Forecast and Analysis 18Step 7: Identify Strategic Opportunities 20Step 8: Final Review and Market Release 21Step 9: Customer Feedback and Market Monitoring 22
PRODUCT ASSESSMENT2.1 INTRODUCTION 232.2 PRODUCT PORTFOLIOS 232.2.1 Bone Graft Substitutes 242.2.2 Growth Factors 302.2.2.1 Other Products 332.2.3 Hyaluronic Acid Viscosupplementation (HAV) 352.3 REGULATORY ISSUES AND RECALLS 382.3.1 Bone Graft Substitutes 3188.8.131.52 Allografts 3184.108.40.206.1 MTF 3220.127.116.11 DBM 318.104.22.168.1 AlloSource 322.214.171.124.2 SeaSpine 3126.96.36.199.3 RTI Surgical 3188.8.131.52 Synthetics 3184.108.40.206.1 Abyrx 3220.127.116.11.2 Zimmer Biomet 402.3.2 Growth Factors 402.3.2.1.1 Medtronic 402.3.3 Hyaluronic Acid Viscosupplementation 418.104.22.168 Three-injection 422.214.171.124.1 Ferring Pharmaceuticals 412.4 CLINICAL TRIALS 422.4.1 Bone Graft Substitutes 4126.96.36.199 Allografts 4188.8.131.52.1 Providence Medical Technology 4184.108.40.206.2 The University of Texas Health Science 4220.127.116.11.3 University of Winchester 418.104.22.168 BDM 422.214.171.124.1 K2M 4126.96.36.199.2 Zimmer Biomet 4188.8.131.52 Synthetics 4184.108.40.206.1 Baxter 4220.127.116.11.2 Bonesupport 418.104.22.168.3 DePuy Synthes 422.214.171.124.4 NuVasive 4126.96.36.199.5 RTI surgical 4188.8.131.52.6 Sunstar GUIDOR 4184.108.40.206 Other materials and comparison 4220.127.116.11.1 Seoul National University Hospital. 418.104.22.168.2 Sewon Cellontech 422.214.171.124.3 SurgaColl Technologies Limited 502.4.1.4.4 University of Colorado 502.4.1.4.5 University of Padova 512.4.2 Growth Factors 5126.96.36.199.1 Bioventus 5188.8.131.52.2 Cerapedics 5184.108.40.206.3 CGBio 5220.127.116.11.4 Isto 518.104.22.168.5 Medtronic 522.214.171.124.6 NuVasive 5126.96.36.199.7 Wright 5188.8.131.52.8 Others 562.4.3 Hyaluronic Acid Viscosupplementation 5184.108.40.206.1 Anika Therapeutics 5220.127.116.11.2 Bioventus 518.104.22.168.3 Cairo University 522.214.171.124.4 Ferring Pharmaceuticals 5126.96.36.199.5 Federal University of Minas Gerais 602.4.3.1.6 Fidia Pharma USA Inc. 602.4.3.1.7 Istituto Ortopedico Rizzoli 6188.8.131.52.8 University Hospital 6184.108.40.206.9 Universidade Nova de Lisboa 62
JAPAN ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW3.1 INTRODUCTION 633.1.1 Bone Graft Substitutes 633.1.2 Growth Factors 633.1.3 Hyaluronic Acid (HA) Viscosupplementation 643.2 CURRENCY EXCHANGE RATE 653.3 MARKET OVERVIEW AND TREND ANALYSIS 663.4 DRIVERS AND LIMITERS 733.4.1 Market Drivers 733.4.2 Market Limiters 733.5 COMPETITIVE MARKET SHARE ANALYSIS 753.6 MERGERS AND ACQUISITIONS 793.7 COMPANY PROFILES 813.7.1 Anika Therapeutics 813.7.2 Bioventus 823.7.3 DePuy Synthes 833.7.4 Ferring Pharmaceuticals 843.7.5 Fidia Pharmaceuticals 853.7.6 Genzyme (Sanofi Group) 863.7.7 Harvest Technologies (Terumo BCT) 873.7.8 Integra LifeSciences 883.7.9 Medtronic 893.7.10 Musculoskeletal Transplant Foundation (MTF) 913.7.11 NuVasive 923.7.12 Orthofix 933.7.13 RTI Surgical 943.7.14 Stryker 953.7.15 Vericel Corporation (formerly Aastrom Bioscience) 963.7.16 Zimmer Biomet 973.8 SWOT ANALYSIS 993.8.1 Anika Therapeutics 993.8.2 Bioventus 1013.8.3 DePuy Synthes 1033.8.4 Ferring Pharmaceuticals 1043.8.5 Fidia Pharmaceuticals 1053.8.7 Harvest Technologies (Terumo BCT) 1073.8.8 Integra LifeSciences 1083.8.9 Medtronic 1093.8.10 Musculoskeletal Transplant Foundation (MTF) 1103.8.11 NuVasive 1113.8.12 Orthofix 1123.8.14 Stryker 1143.8.15 Vericel Corporation (formerly Aastrom Bioscience) 1153.8.16 Zimmer Biomet 116
PROCEDURE NUMBERS4.1 INTRODUCTION 1184.2 PROCEDURES 1194.2.1 Orthopedic Biomaterial Procedures by Segment 1194.2.2 Orthopedic Bone Grafting Procedures 1220.127.116.11 Units per Procedure by Indication 118.104.22.168 Autograft Orthopedic Bone Grafting Procedures by Indication 1244.2.2.3 Synthetic Orthopedic Bone Grafting Procedures by Indication 1274.2.3 Hyaluronic Acid Supplementation Procedures 1304.2.3.1 Hyaluronic Acid Supplementation Procedures by Injection Cycle 130
ORTHOPEDIC BONE GRAFT SUBSTITUTE MARKET5.1 INTRODUCTION 1325.2 MARKET ANALYSIS AND FORECAST 1322.214.171.124 Synthetic Bone Graft Substitute Market 13126.96.36.199.1 Synthetic Bone Graft Substitute Market by Indication 13188.8.131.52 Demineralized Bone Matrix Allograft Bone Graft Substitute Market 1615.3 DRIVERS AND LIMITERS 1625.3.1 Market Drivers 1625.3.2 Market Limiters 1625.4 COMPETITIVE MARKET SHARE ANALYSIS 164
HYALURONIC ACID VISCOSUPPLEMENTATION MARKET6.1 INTRODUCTION 1676.1.1 Benefits of Viscosupplementation 1686.1.2 Synovial Fluid 1686.2 MARKET OVERVIEW 1696.3 MARKET ANALYSIS AND FORECAST 1756.3.1 Total Hyaluronic Acid Viscosupplementation Market 1756.3.2 Three-Injection Hyaluronic Acid Viscosupplementation Market 1776.3.3 Five-Injection Hyaluronic Acid Viscosupplementation Market 1796.4 DRIVERS AND LIMITERS 1816.4.1 Market Drivers 1816.4.2 Market Limiters 1816.5 COMPETITIVE MARKET SHARE ANALYSIS 183
iData’s 9-Step Research MethodologyOur reports follow an in-depth 9-step methodology which focuses on the following research systems:
- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.